LXEO
Lexeo Therapeutics, Inc.
3.30$
-2.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | – | +8,707.7% | +61.0% | +8.6% | -81.1% | |
| – | – | +361.4% | +70.9% | +309.9% | -2.7% | |
| – | +3,923.3% | -70.4% | -17.3% | +84.1% | -448.7% | |
| – | – | +379.3% | -81.7% | +191.5% | -17.5% | |
| – | – | +379.3% | -81.7% | +56,916.4% | -4.1% | |
| – | – | – | – | – | – | |
| – | – | – | – | -111.5% | +30.0% | |
| – | +365.9% | -99.9% | +54,815.9% | -14.5% | +144.2% | |
| – | +264.1% | -151.9% | – | -295.9% | – | |
| – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.